Cargando…
A high-content AlphaScreen™ identifies E6-specific small molecule inhibitors as potential therapeutics for HPV(+) head and neck squamous cell carcinomas
The incidence of human papillomavirus-positive head and neck squamous cell carcinoma (HPV(+)-HNSCC) has increased dramatically over the past decades due to an increase in infection of the oral mucosa by HPV. The etiology of HPV(+)-HNSCC is linked to expression of the HPV oncoprotein, E6, which influ...
Autores principales: | Chitsike, Lennox, Yuan, Chung-Hsiang, Roy, Anuradha, Boyle, Kristopher, Duerksen-Hughes, Penelope J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984827/ https://www.ncbi.nlm.nih.gov/pubmed/33796223 http://dx.doi.org/10.18632/oncotarget.27908 |
Ejemplares similares
-
Targeted Therapy as a Potential De-Escalation Strategy in Locally Advanced HPV-Associated Oropharyngeal Cancer: A Literature Review
por: Chitsike, Lennox, et al.
Publicado: (2021) -
ACE2 : S1 RBD Interaction-Targeted Peptides and Small Molecules as Potential COVID-19 Therapeutics
por: Chitsike, Lennox, et al.
Publicado: (2021) -
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
por: Chitsike, Lennox, et al.
Publicado: (2021) -
PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6
por: Chitsike, Lennox, et al.
Publicado: (2021) -
GA-OH enhances the cytotoxicity of photon and proton radiation in HPV(+) HNSCC cells
por: Chitsike, Lennox, et al.
Publicado: (2023)